Sharda University and Nanoved Research Foundation have developed HARAS, a nanotechnology-based nutraceutical using curcumin to reduce carbon monoxide levels in smokers’ lungs. Clinical trials demonstrated significant reductions in CO levels, affirming HARAS’s efficacy in protecting smokers’ lung health. This breakthrough offers a promising solution to combat smoking-related diseases, with HARAS available in both liquid and capsule forms for convenient access and integration into treatment plans.
Home » Combatting Smoking Risks: HARAS Nanotech Nutraceutical Offers Hope for Lung Health
Combatting Smoking Risks: HARAS Nanotech Nutraceutical Offers Hope for Lung Health
Facebook
Twitter
LinkedIn
Email
WhatsApp
Facebook
Twitter
LinkedIn
Email
WhatsApp
Related Shorts
Elevating Breast Milk Microbiota with Prebiotic Support
February 15, 2025
Dietary Fiber PHGG Boosts Skin Hydration and Elasticity
February 7, 2025
Brussels Chicory for Enhanced Exercise Performance & Recovery
February 7, 2025
Salidroside and exercise performance in healthy active young adults
February 1, 2025
New Study Unveils Powerful Antioxidant Blend for Metabolic Health
February 1, 2025
Quinoa Leaves – Nature’s Nutraceutical Powerhouse
February 1, 2025